WO2004110995A8 - N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors - Google Patents
N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitorsInfo
- Publication number
- WO2004110995A8 WO2004110995A8 PCT/IB2004/001943 IB2004001943W WO2004110995A8 WO 2004110995 A8 WO2004110995 A8 WO 2004110995A8 IB 2004001943 W IB2004001943 W IB 2004001943W WO 2004110995 A8 WO2004110995 A8 WO 2004110995A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- 4alkyl
- 6alkyl
- aryl
- het
- noradrenaline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL04736241T PL1638933T3 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
BRPI0411594-5A BRPI0411594A (en) | 2003-06-17 | 2004-06-07 | n-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline reuptake inhibitors |
YUP-2005/0924A RS20050924A (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re- uptake inhibitors |
AU2004247487A AU2004247487B2 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
DE602004014372T DE602004014372D1 (en) | 2003-06-17 | 2004-06-07 | N-PYRROLIDIN-3-YL-AMIDE DERIVATIVES AS INHIBITORS OF SEROTONIN AND NORADRENALINE RECOVERY |
DK04736241T DK1638933T3 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl amide derivatives as serotonin and noradrenaline reuptake inhibitors |
EP04736241A EP1638933B1 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
NZ544046A NZ544046A (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
EA200501730A EA009881B1 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
CA002530159A CA2530159C (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
AP2005003467A AP2005003467A0 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline reuptake inhibitors. |
MXPA05013960A MXPA05013960A (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors. |
SI200430767T SI1638933T1 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
JP2006516540A JP4137159B2 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline reuptake inhibitors |
UAA200511011A UA80338C2 (en) | 2003-06-17 | 2004-07-06 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors, processes for their preparation, pharmaceutical composition containing them |
IL172063A IL172063A0 (en) | 2003-06-17 | 2005-11-20 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
IS8136A IS8136A (en) | 2003-06-17 | 2005-11-21 | N-pyrrolidin-3-yl-amide derivatives that inhibit serotonin and norepinephrine reuptake |
HR20050993A HRP20050993A2 (en) | 2003-06-17 | 2005-12-14 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
TNP2005000321A TNSN05321A1 (en) | 2003-06-17 | 2005-12-16 | N-PYRROLIDIN-3-YLAMIDE DERIVATIVES AS SEROTONIN AND NORADRENALINE REASSURING INHIBITORS |
NO20060190A NO20060190L (en) | 2003-06-17 | 2006-01-12 | <n-pyrrolidin-3-ylamide derivatives as serotonin and norepinephrine reuptake inhibitors |
HR20080339T HRP20080339T3 (en) | 2003-06-17 | 2008-07-09 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0314048.0A GB0314048D0 (en) | 2003-06-17 | 2003-06-17 | Novel compounds |
GBGB0314048.0 | 2003-06-17 | ||
US49312603P | 2003-08-06 | 2003-08-06 | |
US60/493,126 | 2003-08-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004110995A1 WO2004110995A1 (en) | 2004-12-23 |
WO2004110995A8 true WO2004110995A8 (en) | 2005-04-21 |
Family
ID=33554153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2004/001943 WO2004110995A1 (en) | 2003-06-17 | 2004-06-07 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
Country Status (31)
Country | Link |
---|---|
US (2) | US7378436B2 (en) |
EP (1) | EP1638933B1 (en) |
JP (1) | JP4137159B2 (en) |
KR (1) | KR100803796B1 (en) |
AP (1) | AP2005003467A0 (en) |
AR (1) | AR044715A1 (en) |
AT (1) | ATE398107T1 (en) |
AU (1) | AU2004247487B2 (en) |
BR (1) | BRPI0411594A (en) |
CA (1) | CA2530159C (en) |
CY (1) | CY1110434T1 (en) |
DE (1) | DE602004014372D1 (en) |
DK (1) | DK1638933T3 (en) |
EA (1) | EA009881B1 (en) |
EC (1) | ECSP056232A (en) |
ES (1) | ES2305776T3 (en) |
HR (2) | HRP20050993A2 (en) |
IL (1) | IL172063A0 (en) |
IS (1) | IS8136A (en) |
MA (1) | MA27885A1 (en) |
MX (1) | MXPA05013960A (en) |
NL (1) | NL1026438C2 (en) |
NZ (1) | NZ544046A (en) |
PA (1) | PA8605301A1 (en) |
PE (1) | PE20050631A1 (en) |
PL (1) | PL1638933T3 (en) |
PT (1) | PT1638933E (en) |
SI (1) | SI1638933T1 (en) |
TW (1) | TW200505852A (en) |
UY (1) | UY28360A1 (en) |
WO (1) | WO2004110995A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4898073B2 (en) | 2000-07-31 | 2012-03-14 | ニュコメデ ダンマルク アンパーツセルスカブ | Fentanyl composition for intranasal administration |
BRPI0411594A (en) * | 2003-06-17 | 2006-08-29 | Pfizer | n-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline reuptake inhibitors |
EP1805165B1 (en) | 2004-10-18 | 2009-12-16 | Eli Lilly And Company | 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mglur3 receptor antagonists |
US7122683B2 (en) | 2004-11-23 | 2006-10-17 | Pfizer Inc. | Amides useful as monoamine re-uptake inhibitors |
GB0425766D0 (en) * | 2004-11-23 | 2004-12-22 | Pfizer Ltd | Novel compounds |
CA2590229A1 (en) * | 2004-12-14 | 2006-06-22 | Pfizer Limited | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
CA2590226A1 (en) * | 2004-12-14 | 2006-06-22 | Pfizer Limited | N-pyrrolidin-3yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
TWI410406B (en) | 2005-05-13 | 2013-10-01 | Otsuka Pharma Co Ltd | Pyrrolidine compound |
RU2403250C2 (en) * | 2005-06-02 | 2010-11-10 | Ф.Хоффманн-Ля Рош Аг | Pyperidin-4-ylamide derivatives and their application as antagonists of sst receptor subtupe 5 |
WO2007135530A2 (en) * | 2006-05-22 | 2007-11-29 | Pfizer Limited | Pharmaceutically & veterinarily suitable salt |
US20080014152A1 (en) * | 2006-07-13 | 2008-01-17 | Di Mauro Thomas M | Intranasal delivery of clenbuterol across the cribriform plate and into the brain |
JP5219465B2 (en) * | 2006-11-10 | 2013-06-26 | 大塚製薬株式会社 | Medicine |
US20100056497A1 (en) * | 2007-01-31 | 2010-03-04 | Dainippon Sumitomo Pharma Co., Ltd | Amide derivative |
JP2010189275A (en) * | 2007-06-14 | 2010-09-02 | Dainippon Sumitomo Pharma Co Ltd | Naphthalene derivative |
US8263652B2 (en) | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
RU2010129690A (en) | 2007-12-19 | 2012-01-27 | Дайниппон Сумитомо Фарма Ко., Лтд. (Jp) | BICYCLIC HETEROCYCLIC DERIVATIVES |
TWI438190B (en) | 2008-07-24 | 2014-05-21 | Theravance Inc | 3-(phenoxyphenylmethyl)pyrrolidine compounds |
TWI443087B (en) | 2008-11-14 | 2014-07-01 | Theravance Inc | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
JP2012524098A (en) * | 2009-04-15 | 2012-10-11 | セラヴァンス, インコーポレーテッド | 3- (phenoxypyrrolidin-3-yl-methyl) heteroaryl, 3- (phenylpyrrolidin-3-ylmethoxy) heteroaryl and 3- (heteroarylpyrrolidin-3-ylmethoxy) heteroaryl compounds |
EP2447264A4 (en) | 2009-06-24 | 2012-12-12 | Dainippon Sumitomo Pharma Co | N-substituted-cyclic amino derivative |
AU2010273645B2 (en) * | 2009-07-13 | 2014-12-04 | Theravance Biopharma R&D Ip, Llc | 3-phenoxymethylpyrrolidine compounds |
ES2495366T3 (en) | 2009-07-21 | 2014-09-17 | Theravance, Inc. | 3-phenoxymethylpyrrolidine compounds |
EP2523945A1 (en) * | 2010-01-11 | 2012-11-21 | Theravance, Inc. | 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors |
JP5769348B2 (en) * | 2010-03-22 | 2015-08-26 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | 1- (2-phenoxymethylheteroaryl) piperidine compound and 1- (2-phenoxymethylheteroaryl) piperazine compound |
ES2533434T3 (en) | 2010-10-11 | 2015-04-10 | Theravance Biopharma R&D Ip, Llc | Serotonin uptake inhibitors |
US8501964B2 (en) | 2010-12-03 | 2013-08-06 | Theravance, Inc. | Serotonin reuptake inhibitors |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE138773C (en) | ||||
US3963745A (en) | 1972-04-03 | 1976-06-15 | A. H. Robins Company, Incorporated | Method for controlling emesis with N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides |
US4002757A (en) * | 1974-12-26 | 1977-01-11 | A. H. Robins Company, Incorporated | N-(1-substituted-3-pyrrolidinyl)-4-quinolinecarboxamides |
US4020072A (en) | 1976-05-04 | 1977-04-26 | E. R. Squibb & Sons, Inc. | 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines |
GB1574419A (en) * | 1977-11-11 | 1980-09-03 | Anphar Sa | Piperidine compounds |
CH628885A5 (en) * | 1978-01-01 | 1982-03-31 | Anphar Sa | Piperidine derivative |
US5130312A (en) * | 1987-07-17 | 1992-07-14 | Janssen Pharmaceutica N.V. | Substituted N-(3-hydroxy-4-piperidinyl)benzamides |
FR2642069B1 (en) | 1989-01-20 | 1991-04-12 | Rhone Poulenc Sante | NOVEL BENZOPYRAN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
WO1997018813A1 (en) | 1995-11-22 | 1997-05-29 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
AU4167099A (en) | 1998-06-19 | 2000-01-05 | Nissan Chemical Industries Ltd. | Heterocyclic compounds as hypoglycemic agents |
US6670299B1 (en) * | 1999-07-03 | 2003-12-30 | Northwestern University | Cyclopentadienyl-containing low-valent early transition metal olefin polymerization catalysts |
FR2802206B1 (en) * | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | 4-AMINOPIPERIDINE DERIVATIVES AND THEIR USE AS MEDICINAL PRODUCTS |
ES2275670T3 (en) | 2000-03-03 | 2007-06-16 | EISAI R&D MANAGEMENT CO., LTD. | NEW METHODS USING CHOLESTERASE INHIBITORS. |
ES2278729T3 (en) * | 2000-03-06 | 2007-08-16 | Acadia Pharmaceuticals Inc. | AZACICLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES RELATED TO SEROTONIN. |
WO2002024694A1 (en) | 2000-09-22 | 2002-03-28 | Smithkline Beecham, P.L.C. | Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
HUP0303360A2 (en) | 2000-09-25 | 2004-01-28 | Actelion Pharmaceuticals Ltd. | Substituted amino-aza-cycloalkanes useful against malaria and pharmaceutical compositions containing them |
DE60237528D1 (en) | 2001-09-14 | 2010-10-14 | High Point Pharmaceuticals Llc | NEW AMINOAZETIDIN, AMINOPYRROLIDIN AND AMINOPIPERIDINE DERIVATIVES |
WO2003037865A1 (en) | 2001-10-31 | 2003-05-08 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Novel anticancer compounds |
GB0128287D0 (en) | 2001-11-26 | 2002-01-16 | Smithkline Beecham Plc | Novel method and compounds |
JP2005533813A (en) * | 2002-06-24 | 2005-11-10 | アカディア ファーマシューティカルズ,インコーポレーテッド | N-substituted piperidine derivatives as serotonin receptor agonists |
WO2004009549A2 (en) | 2002-07-18 | 2004-01-29 | Actelion Pharmaceuticals Ltd | Piperidines useful for the treatment of central nervous system disorders |
WO2004022536A1 (en) | 2002-09-04 | 2004-03-18 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
WO2004058705A2 (en) | 2002-12-20 | 2004-07-15 | Chemocentryx | Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
BRPI0411594A (en) * | 2003-06-17 | 2006-08-29 | Pfizer | n-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline reuptake inhibitors |
-
2004
- 2004-06-07 BR BRPI0411594-5A patent/BRPI0411594A/en not_active IP Right Cessation
- 2004-06-07 SI SI200430767T patent/SI1638933T1/en unknown
- 2004-06-07 EA EA200501730A patent/EA009881B1/en not_active IP Right Cessation
- 2004-06-07 MX MXPA05013960A patent/MXPA05013960A/en active IP Right Grant
- 2004-06-07 JP JP2006516540A patent/JP4137159B2/en not_active Expired - Fee Related
- 2004-06-07 AU AU2004247487A patent/AU2004247487B2/en not_active Expired - Fee Related
- 2004-06-07 PT PT04736241T patent/PT1638933E/en unknown
- 2004-06-07 PL PL04736241T patent/PL1638933T3/en unknown
- 2004-06-07 WO PCT/IB2004/001943 patent/WO2004110995A1/en active IP Right Grant
- 2004-06-07 EP EP04736241A patent/EP1638933B1/en active Active
- 2004-06-07 AP AP2005003467A patent/AP2005003467A0/en unknown
- 2004-06-07 KR KR1020057024147A patent/KR100803796B1/en not_active IP Right Cessation
- 2004-06-07 CA CA002530159A patent/CA2530159C/en not_active Expired - Fee Related
- 2004-06-07 ES ES04736241T patent/ES2305776T3/en active Active
- 2004-06-07 DK DK04736241T patent/DK1638933T3/en active
- 2004-06-07 NZ NZ544046A patent/NZ544046A/en unknown
- 2004-06-07 AT AT04736241T patent/ATE398107T1/en not_active IP Right Cessation
- 2004-06-07 DE DE602004014372T patent/DE602004014372D1/en active Active
- 2004-06-14 UY UY28360A patent/UY28360A1/en not_active Application Discontinuation
- 2004-06-14 PE PE2004000590A patent/PE20050631A1/en not_active Application Discontinuation
- 2004-06-16 PA PA20048605301A patent/PA8605301A1/en unknown
- 2004-06-16 TW TW093117317A patent/TW200505852A/en unknown
- 2004-06-16 AR ARP040102082A patent/AR044715A1/en not_active Application Discontinuation
- 2004-06-17 US US10/872,160 patent/US7378436B2/en not_active Expired - Fee Related
- 2004-06-17 NL NL1026438A patent/NL1026438C2/en not_active IP Right Cessation
-
2005
- 2005-11-20 IL IL172063A patent/IL172063A0/en unknown
- 2005-11-21 IS IS8136A patent/IS8136A/en unknown
- 2005-12-14 HR HR20050993A patent/HRP20050993A2/en not_active Application Discontinuation
- 2005-12-16 EC EC2005006232A patent/ECSP056232A/en unknown
- 2005-12-16 MA MA28674A patent/MA27885A1/en unknown
-
2008
- 2008-05-21 US US12/124,755 patent/US20080306123A1/en not_active Abandoned
- 2008-07-09 HR HR20080339T patent/HRP20080339T3/en unknown
- 2008-08-14 CY CY20081100869T patent/CY1110434T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004110995A8 (en) | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors | |
WO2005097129A3 (en) | 6-azaindole compound | |
WO2005060972A3 (en) | Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection | |
WO2007016392A3 (en) | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors | |
PL1635835T3 (en) | 2-aminopyrimidine derivatives as raf kinase inhibitors | |
EP1460067A4 (en) | Bicyclic derivative, process for producing the same, and use | |
WO2001017972A3 (en) | Novel herbicides | |
GB0123589D0 (en) | Organic compounds | |
WO2005092858A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist | |
WO2004018449A8 (en) | Piperidine-derivatives as pde4 inhibitors | |
WO2005074603A3 (en) | Aminobenzoxazoles as therapeutic agents | |
CA2441313A1 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
WO2004037811A8 (en) | Selected cgrp antagonists, method for production and use thereof as medicament | |
WO2005105096A3 (en) | Fused heterocyclic compounds | |
EP1527049B8 (en) | Fused heterocyclic compounds as peptidase inhibitors | |
EP1396493A4 (en) | Heterocyclic compounds | |
WO2005021497A3 (en) | Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones | |
WO2005021495A3 (en) | Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones | |
WO2004031145A3 (en) | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors | |
WO2004014388A8 (en) | 6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors | |
WO2003022838A8 (en) | Pyridine substituted furan derivatives as raf kinase inhibitors | |
WO2004099197A3 (en) | Substituted oxyarenes, and use thereof for controlling pests | |
WO2009020137A1 (en) | Aminopyrazole amide derivative | |
WO2005005389A3 (en) | Malonamide derivatives | |
WO2004052891A8 (en) | Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 52/2004 UNDER (72, 75) REPLACE "PFIZER CENTRAL RESEARCH & DEVELOPMENT" BY "PFIZER GLOBAL RESEARCH & DEVELOPMENT" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005/09132 Country of ref document: ZA Ref document number: 200509132 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5225/DELNP/2005 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004247487 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 172063 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20050409 Country of ref document: UZ Ref document number: 200501730 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: CR2005-008123 Country of ref document: CR |
|
ENP | Entry into the national phase |
Ref document number: 2004247487 Country of ref document: AU Date of ref document: 20040607 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: AP/P/2005/003467 Country of ref document: AP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004247487 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 544046 Country of ref document: NZ Ref document number: 05124742 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12005502249 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20050993A Country of ref document: HR |
|
WWE | Wipo information: entry into national phase |
Ref document number: P-2005/0924 Country of ref document: YU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057024147 Country of ref document: KR Ref document number: 2006516540 Country of ref document: JP Ref document number: 9116 Country of ref document: GE Ref document number: 2530159 Country of ref document: CA Ref document number: 2004736241 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048172229 Country of ref document: CN Ref document number: PA/a/2005/013960 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200600080 Country of ref document: VN |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 52/2004 UNDER (72, 75) THE NATIONALITY AND RESIDENCE OF "WAKENHUT, FLORIAN" SHOULD READ "¢FR/GB!" |
|
WWP | Wipo information: published in national office |
Ref document number: 2004736241 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057024147 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0411594 Country of ref document: BR |
|
WWG | Wipo information: grant in national office |
Ref document number: 2004736241 Country of ref document: EP |